GO:0006235 dTTP biosynthetic process: Nucleotide Metabolism Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006235 dTTP biosynthetic process describes the chemical reactions and pathways that produce dTTP, the immediate precursor for DNA synthesis.
• The pathway is essential for maintaining balanced deoxynucleotide pools, which is critical for genome stability and cell cycle progression [3,4].
• Key enzymes include thymidylate synthase (TYMS), thymidine kinase 1 (TK1), thymidylate kinase (DTYMK), and ribonucleotide reductase (RNR) [4,6].
• dTTP biosynthesis is tightly regulated and coordinated with DNA replication to prevent mutagenesis and replication stress.
• Dysregulation of dTTP metabolism is linked to cancer, mitochondrial disorders, and antiviral/chemotherapeutic resistance [1,3,8].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of dTTP pathway genes in disease and drug response [6,8].
Description
The dTTP biosynthetic process (GO:0006235) encompasses the enzymatic steps that generate deoxythymidine triphosphate (dTTP), one of the four building blocks of DNA. This pathway ensures that cells have sufficient dTTP for DNA replication and repair while avoiding imbalances that can cause mutations or cell death [3,4]. Understanding dTTP biosynthesis is fundamental to cancer research, antiviral drug development, and studies of mitochondrial function, because many chemotherapeutic and antiviral agents target enzymes in this pathway [4,8]. Recent work has also highlighted the importance of dTTP pool regulation in mitotic control and genome stability. Researchers use gene editing and biochemical assays to map the pathway and identify therapeutic vulnerabilities [6,8].
dTTP biosynthetic process At A Glance
| GO ID | GO:0006235 |
|---|---|
| GO term | dTTP biosynthetic process |
| Ontology | biological_process |
| Synonym | dTTP anabolism; dTTP biosynthesis; dTTP formation; dTTP synthesis |
| Major function | Production of dTTP for DNA replication and repair |
| Key enzymes | TYMS, TK1, DTYMK, RRM1/RRM2, NME1/2 |
| Pathway context | Pyrimidine deoxyribonucleotide metabolism |
| Regulation | Cell cycle-dependent, feedback inhibition by dTTP |
| Disease relevance | Cancer, mitochondrial disorders, antiviral resistance |
What Is GO:0006235?
GO:0006235 dTTP biosynthetic process is defined as the chemical reactions and pathways resulting in the formation of dTTP, deoxyribosylthymine triphosphate. In simpler terms, it is the set of enzymatic steps that build dTTP from precursors, including both de novo synthesis and salvage pathways, to supply the nucleotide needed for DNA synthesis [3,4].
Why Is dTTP biosynthetic process Important in Cell Biology?
dTTP biosynthesis is essential for DNA replication and repair, and its dysregulation leads to genome instability, replication stress, and cell death [3,4]. Many anticancer and antiviral drugs target enzymes in this pathway, making it a focal point for therapeutic development [4,8]. Additionally, proper dTTP pool regulation is required for mitochondrial DNA maintenance and normal development, as highlighted by studies linking folate metabolism and mitochondrial translation to dTTP synthesis.
• Provides dTTP for DNA replication and repair.
• Maintains balanced deoxynucleotide pools to prevent mutagenesis.
• Target of anticancer drugs such as 5-fluorouracil and methotrexate.
• Target of antiviral nucleoside analogs.
• Linked to mitochondrial DNA maintenance and mitochondrial disorders.
• Regulated during the cell cycle to coordinate with DNA synthesis.
• Involved in thymidylate synthase inhibition and chemoresistance.
• Enables studies of nucleotide pool imbalance and replication stress.
• Relevant to CRISPR screening for metabolic vulnerabilities.
• Supports development of prodrug strategies for nucleotide analogs.
What Happens During dTTP biosynthetic process?
De Novo Synthesis of dTMP
In simple terms: The cell builds thymidine monophosphate (dTMP) from scratch using folate and other molecules.
The de novo pathway begins with the conversion of dUMP to dTMP by thymidylate synthase (TYMS), which uses 5,10-methylenetetrahydrofolate as a methyl donor. This step is a key regulatory point and is inhibited by fluoropyrimidines such as 5-fluorouracil. Folate metabolism is therefore intimately linked to dTTP biosynthesis, as demonstrated by studies showing that mitochondrial translation requires folate-dependent tRNA methylation.
Phosphorylation Cascade to dTTP
In simple terms: dTMP is converted to dTDP and then to dTTP by adding two phosphate groups.
dTMP is phosphorylated to dTDP by thymidylate kinase (DTYMK), and dTDP is further phosphorylated to dTTP by nucleoside diphosphate kinase (NME1/2) or other kinases. DTYMK is essential for this step, and its molecular characterization in Drosophila melanogaster has provided insights into its catalytic mechanism and substrate specificity. This phosphorylation cascade ensures that dTTP is available for DNA polymerases during S phase.
Salvage Pathway
In simple terms: The cell can also recycle thymidine from the environment to make dTTP.
The salvage pathway converts thymidine to dTMP via thymidine kinase 1 (TK1), which is cell cycle-regulated and peaks during S phase. This pathway is particularly important in cells that lack de novo synthesis capacity, and it is a target for nucleoside analog prodrugs that require phosphorylation for activation. Membrane-permeable triphosphate prodrugs of nucleoside analogues have been developed to bypass kinase dependence.
Regulation of dTTP Pools
In simple terms: The cell carefully controls how much dTTP is made to avoid mistakes during DNA copying.
dTTP biosynthesis is regulated by feedback inhibition of ribonucleotide reductase (RNR) by dTTP and by cell cycle-dependent expression of enzymes such as TK1 and DTYMK [3,4]. Mitotic control of dTTP pools is necessary to prevent replication stress and genome instability. Additionally, dTTP pool imbalance can lead to misincorporation of nucleotides into DNA, which is a source of mutations.
Integration with DNA Replication
In simple terms: dTTP is delivered to the DNA replication machinery when DNA is copied.
dTTP is used by DNA polymerases during DNA replication and repair. In vitro studies using cytoplasmic extracts from African swine fever virus-infected cells have shown that dTTP is required for viral DNA replication, highlighting the pathway's role in viral propagation. The coordination between dTTP synthesis and DNA replication is critical for maintaining genome integrity.
Key Genes Involved in GO:0006235 dTTP biosynthetic process
The following genes encode enzymes and regulatory proteins directly involved in dTTP biosynthesis and its coordination with DNA replication.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYMS | Converts dUMP to dTMP using folate | Target of 5-fluorouracil; linked to chemoresistance |
| TK1 | Salvage pathway; phosphorylates thymidine to dTMP | Cell cycle marker; target for nucleoside analogs |
| DTYMK | Phosphorylates dTMP to dTDP | Essential for dTTP synthesis; studied in Drosophila |
| NME1 | Nucleoside diphosphate kinase; dTDP to dTTP | Metastasis suppressor; involved in nucleotide metabolism |
| NME2 | Nucleoside diphosphate kinase; dTDP to dTTP | Regulates dTTP pools; potential drug target |
| RRM1 | Ribonucleotide reductase subunit; reduces NDPs to dNDPs | Target of gemcitabine; feedback inhibited by dTTP |
| RRM2 | Ribonucleotide reductase subunit; reduces NDPs to dNDPs | Cell cycle-regulated; target of anticancer drugs |
| MTHFD2 | Mitochondrial folate metabolism | Supports dTMP synthesis; linked to cancer |
| SHMT2 | Serine hydroxymethyltransferase; folate metabolism | Provides one-carbon units for dTMP synthesis |
| MTR | Methionine synthase; folate cycle | Indirectly supports dTTP synthesis |
| DHFR | Dihydrofolate reductase; folate metabolism | Target of methotrexate; affects dTTP synthesis |
| ATIC | AICAR transformylase; purine biosynthesis | Cross-talk with pyrimidine metabolism |
| GART | Glycinamide ribonucleotide transformylase | Folate-dependent; affects nucleotide pools |
| TYMP | Thymidine phosphorylase; thymidine catabolism | Regulates thymidine availability |
| NT5C | Nucleotidase; dephosphorylates nucleotides | Modulates dTTP pools |
| DUT | dUTPase; hydrolyzes dUTP to dUMP | Prevents dUTP incorporation into DNA |
| UNG | Uracil-DNA glycosylase; repairs dUTP misincorporation | Genome stability |
How Is dTTP biosynthetic process Regulated?
dTTP biosynthesis is regulated at multiple levels. Ribonucleotide reductase (RNR) is allosterically inhibited by dTTP, ensuring balanced deoxynucleotide pools. Cell cycle-dependent expression of TK1 and DTYMK peaks during S phase, coordinating dTTP supply with DNA replication. Folate metabolism provides one-carbon units for dTMP synthesis, and mitochondrial folate enzymes such as MTHFD2 and SHMT2 support this process. Additionally, dTTP pool size is influenced by salvage and catabolic enzymes, including TYMP and NT5C [3,4].
dTTP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYMS | Colorectal cancer, chemoresistance | Knockout and point mutation in HCT116 cells |
| RRM1 | Lung cancer, gemcitabine resistance | Knock-in of resistance mutations in A549 cells |
| DTYMK | Mitochondrial DNA depletion, drug sensitivity | Knockout in HeLa cells |
| TK1 | Cancer biomarker, antiviral resistance | Overexpression in HEK293T cells |
| MTHFD2 | Cancer metabolism, mitochondrial disease | Knockout in cancer cell lines |
Cancer
Altered dTTP biosynthesis is a hallmark of many cancers. TYMS overexpression confers resistance to 5-fluorouracil, while RRM1 and RRM2 are targets of gemcitabine and other nucleoside analogs. Folate-dependent enzymes such as MTHFD2 and SHMT2 are upregulated in tumors to support increased dTTP demand. Targeting dTTP synthesis is a validated anticancer strategy.
Mitochondrial Disorders
Mitochondrial translation requires folate-dependent tRNA methylation, which is linked to dTTP synthesis. Defects in mitochondrial folate metabolism can impair dTTP production and lead to mitochondrial DNA depletion syndromes. Understanding these connections may reveal therapeutic approaches for mitochondrial diseases.
Viral Infections
Many viruses, including African swine fever virus, depend on host dTTP biosynthesis for DNA replication. Antiviral nucleoside analogs target viral polymerases but often require phosphorylation by host kinases, linking dTTP metabolism to antiviral efficacy. Membrane-permeable triphosphate prodrugs can bypass kinase dependence and improve antiviral activity.
Drug Resistance
Mutations in dTTP biosynthetic enzymes, such as DTYMK or TK1, can alter sensitivity to nucleoside analogs [6,8]. Understanding these mechanisms is critical for designing next-generation therapeutics.
From dTTP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TYMS loss affect dTTP pools and DNA replication? | TYMS knockout in HCT116 cells |
| How do DTYMK mutations alter dTTP synthesis? | Point mutation knock-in in HeLa cells |
| Can TK1 overexpression rescue dTTP depletion? | TK1 overexpression in HEK293T cells |
| What is the role of RRM1 in drug resistance? | RRM1 knockout and knock-in in A549 cells |
| Does MTHFD2 support dTTP synthesis in mitochondria? | MTHFD2 knockout in cancer cells |
| Can prodrugs bypass kinase dependence? | Triphosphate prodrug treatment in kinase-deficient cells |
How to Study the dTTP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC-MS | dTTP and deoxynucleotide pools | Quantify dTTP levels in edited cells |
| Enzyme activity assay | TYMS, TK1, DTYMK activity | Validate CRISPR knockouts |
| BrdU incorporation | DNA synthesis rate | Assess replication stress |
| Flow cytometry | Cell cycle distribution | Link dTTP to S phase progression |
| CRISPR screen | Gene essentiality and drug sensitivity | Identify dTTP pathway vulnerabilities |
| RNA-seq | Transcriptional changes | Analyze pathway regulation |
| Proteomics | Protein expression and modifications | Study enzyme abundance |
| Metabolomics | Global metabolite profiling | Discover metabolic crosstalk |
Nucleotide Pool Analysis
High-performance liquid chromatography (HPLC) and mass spectrometry are used to quantify dTTP and other deoxynucleotide pools in cells and tissues [3,4]. These methods are essential for assessing the impact of gene edits on dTTP biosynthesis.
Enzyme Activity Assays
Enzymatic assays measure the activity of TYMS, TK1, DTYMK, and RNR using radiolabeled substrates or spectrophotometric methods [4,6]. These assays help validate CRISPR-edited cell lines and identify inhibitors.
DNA Replication and Cell Cycle Analysis
BrdU incorporation, flow cytometry, and DNA fiber assays assess DNA replication and cell cycle progression in cells with altered dTTP synthesis. These methods link dTTP pools to replication stress and genome stability.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to dTTP synthesis inhibitors. Bioinformatics analysis of RNA-seq and proteomics data reveals pathway crosstalk and regulatory networks.
How CRISPR Can Be Used to Study GO:0006235 dTTP biosynthetic process
Knockout
CRISPR knockout of TYMS, DTYMK, or TK1 can abolish dTTP synthesis, leading to cell cycle arrest or death. These models are used to study pathway essentiality and to validate drug targets.
Point Mutation
Point mutations in DTYMK or RRM1 can mimic clinical resistance alleles or alter catalytic activity. Knock-in of these mutations allows precise structure-function studies and drug sensitivity testing.
Knock-in
Knock-in of tagged versions of TYMS or TK1 enables live-cell imaging and proteomic analysis of dTTP enzymes. This approach helps track enzyme localization and interactions.
Overexpression
Overexpression of TK1 or RRM2 can increase dTTP pools and confer resistance to nucleoside analogs [4,8]. These models are useful for studying drug resistance mechanisms.
How EDITGENE Supports dTTP biosynthetic process Research
Researchers studying dTTP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in dTTP production, drug response, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for dTTP biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CMPK2 Knockout HEK293 Cell Line | EDJ-KQ9220 | Human | 129607 | Details Get a Quote |
| TYMS Knockout HEK293 Cell Line | EDJ-KQ17847 | Human | 7298 | Details Get a Quote |
| TYMS Knockout A-549 Cell Line | EDJ-KQ29560 | Human | 7298 | Details Get a Quote |
| TYMS Knockout HCT 116 Cell Line | EDJ-KQ29561 | Human | 7298 | Details Get a Quote |
| TYMS Knockout HeLa Cell Line | EDJ-KQ29562 | Human | 7298 | Details Get a Quote |
| CMPK2 Knockout HCT 116 Cell Line | EDJ-KQ35792 | Human | 129607 | Details Get a Quote |
| NME3 Knockout HEK293 Cell Line | EDJ-KQ50483 | Human | 4832 | Details Get a Quote |
| NME3 Knockout HeLa Cell Line | EDJ-KQ54001 | Human | 4832 | Details Get a Quote |
| CMPK2 Knockout HeLa Cell Line | EDJ-KQ58264 | Human | 129607 | Details Get a Quote |
| NME3 Knockout A-549 Cell Line | EDJ-KQ62494 | Human | 4832 | Details Get a Quote |
| CMPK2 Knockout A-549 Cell Line | EDJ-KQ66751 | Human | 129607 | Details Get a Quote |
| NME3 Knockout HCT 116 Cell Line | EDJ-KQ70960 | Human | 4832 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About dTTP biosynthetic process
What is dTTP biosynthetic process?
It is the set of enzymatic reactions that produce dTTP, the nucleotide used in DNA synthesis.
What genes are involved in dTTP biosynthetic process?
Key genes include TYMS, TK1, DTYMK, RRM1, RRM2, and NME1/2 [4,6].
Why is dTTP biosynthesis important for cancer?
Many cancers upregulate dTTP synthesis to support rapid proliferation, and drugs like 5-fluorouracil target this pathway.
How is dTTP biosynthesis regulated?
It is regulated by feedback inhibition of ribonucleotide reductase and cell cycle-dependent expression of enzymes like TK1 [3,4].
What diseases are linked to dTTP biosynthesis defects?
Cancer, mitochondrial disorders, and viral infections are linked to dTTP pathway alterations [1,2,4].
What methods are used to study dTTP biosynthesis?
HPLC-MS, enzyme activity assays, CRISPR screens, and metabolomics are commonly used [3,6].
Can CRISPR be used to study dTTP biosynthesis?
Yes, CRISPR knockout, knock-in, and point mutation models enable precise dissection of the pathway [6,8].
What is the role of thymidylate synthase in dTTP synthesis?
TYMS converts dUMP to dTMP, a critical step in de novo dTTP synthesis.
How does dTTP pool imbalance affect cells?
Imbalance can cause DNA mutations, replication stress, and cell death [3,4].
What is the connection between folate metabolism and dTTP synthesis?
Folate provides one-carbon units for dTMP synthesis, and mitochondrial folate enzymes support this process.
Conclusion
The dTTP biosynthetic process (GO:0006235) is a central metabolic pathway that supplies the nucleotide building block for DNA replication and repair. Its tight regulation is essential for genome stability, and its dysregulation is implicated in cancer, mitochondrial disorders, and viral infections. CRISPR-based models and advanced analytical methods continue to uncover new layers of regulation and therapeutic opportunities. EDITGENE offers comprehensive services to accelerate research in this field.
References
- 1. Morscher RJ et al.. 2018. Mitochondrial translation requires folate-dependent tRNA methylation.. Nature 554(7690):128-132 PMID: 29364879
- 2. Caeiro F et al.. 1990. In vitro DNA replication by cytoplasmic extracts from cells infected with African swine fever virus.. Virology 179(1):87-94 PMID: 2219742
- 3. Hu CM et al.. 2007. Mitotic control of dTTP pool: a necessity or coincidence?. J Biomed Sci 14(4):491-7 PMID: 17525869
- 4. Reichard P. 1985. Ribonucleotide reductase and deoxyribonucleotide pools.. Basic Life Sci 31:33-45 PMID: 3888178
- 6. Hu Frisk J et al.. 2024. Molecular characterization of Drosophila melanogaster thymidylate kinase.. Nucleosides Nucleotides Nucleic Acids 43(8):734-742 PMID: 38518117
- 8. Gollnest T et al.. 2016. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.. Angew Chem Int Ed Engl 55(17):5255-8 PMID: 27008042
